Zobrazeno 1 - 10
of 461
pro vyhledávání: '"Rémi Rabasa‐Lhoret"'
Autor:
Noémie Bélanger, Anne Bonhoure, Tamizan Kherani, Valérie Boudreau, François Tremblay, Annick Lavoie, Maite Carricart, Ashish Marwaha, Rémi Rabasa-Lhoret, Kathryn J. Potter
Publikováno v:
Genetics and Molecular Biology, Vol 47, Iss 1 (2024)
Abstract People living with cystic fibrosis (pwCF) homozygous for F508del present more severe phenotypes. PwCF with compound heterozygous genotypes F508del /A455E and F508del /L206W may have milder cystic fibrosis (CF) phenotypes. We compared F508del
Externí odkaz:
https://doaj.org/article/08515ed6cdce4296a264c67c8b40e92b
Autor:
Sylvain Iceta, Léonie Sohier, Catherine Bégin, Anne-Sophie Brazeau, Rémi Rabasa-Lhoret, Claudia Gagnon
Publikováno v:
BMC Endocrine Disorders, Vol 22, Iss 1, Pp 1-9 (2022)
Abstract Background People living with type 1 diabetes (PWT1D) are at increased risk for impairments in brain function, which may impact on daily life. Cognitive impairments in PWT1D might contribute to increasing eating disorders, reducing self-mana
Externí odkaz:
https://doaj.org/article/ba4238ac64a043b0b11ea3351e17e927
Autor:
Florence Racine, Miguel Chagnon, Valérie Boudreau, Katherine Desjardins, Cécile Q.T. Nguyen, Marie-Hélène Denis, Rémi Rabasa-Lhoret, Geneviève Mailhot
Publikováno v:
Diabetes Epidemiology and Management, Vol 11, Iss , Pp 100141- (2023)
AIMS: Data on the clinical course of patients with cystic fibrosis (CF) from childhood to CF-related diabetes (CFRD) diagnosis in adulthood are limited. We evaluate whether childhood trajectories of parameters of interest in CF are associated with th
Externí odkaz:
https://doaj.org/article/f83d75d59aa84754b03b083d6ca98747
Autor:
Nadine Taleb, Véronique Gingras, Ran Cheng, Valérie Parent, Virginie Messier, Danijela Bovan, Azadeh Shohoudi, Anne-Sophie Brazeau, Rémi Rabasa-Lhoret
Publikováno v:
Frontiers in Endocrinology, Vol 14 (2023)
AimsNon-severe hypoglycemia (NS-H) is challenging for people living with type 1 diabetes (PWT1D) and often results from relative iatrogenic hyper-insulinemia. Current guidelines recommend a one-size-fits-all approach of 15–20 g of simple carbohydra
Externí odkaz:
https://doaj.org/article/065b3314fc0d43e680d11a58f11811cc
Autor:
Joséphine Molveau, Rémi Rabasa-Lhoret, Étienne Myette-Côté, Virginie Messier, Corinne Suppère, Kathryn J. Potter, Elsa Heyman, Sémah Tagougui
Publikováno v:
Frontiers in Endocrinology, Vol 13 (2022)
ObjectiveStudies investigating strategies to limit the risk of nocturnal hypoglycemia associated with physical activity (PA) are scarce and have been conducted in standardized, controlled conditions in people with type 1 diabetes (T1D). This study so
Externí odkaz:
https://doaj.org/article/7ebfab1410ac4489ad2c4ff1ae7ca370
Publikováno v:
Frontiers in Endocrinology, Vol 12 (2021)
Cystic fibrosis (CF) is a genetic disease caused by mutations in the cystic fibrosis transmembrane conductance regulator gene (CFTR). Cystic fibrosis-related diabetes (CFRD) is the most common comorbidity, affecting more than 50% of adult CF patients
Externí odkaz:
https://doaj.org/article/f66df1bd40aa4e97abecaca84d2c10ac
Autor:
Quitterie Reynaud, Valérie Boudreau, Sandrine Touzet, Katherine Desjardins, Stéphanie Poupon Bourdy, Emilie Blond, Yves Berthiaume, Rémi Rabasa-Lhoret, Isabelle Durieu
Publikováno v:
Scientific Reports, Vol 9, Iss 1, Pp 1-8 (2019)
Abstract Cystic fibrosis (CF)-related diabetes is associated with increased mortality. We analysed the clinical and glycemic profiles of two cohorts of patients treated according to the same guidelines in France and Canada. To investigate incidence d
Externí odkaz:
https://doaj.org/article/ea68f3c1206447ae808634324d5b1e4c
Autor:
Valérie Boudreau, Quitterie Reynaud, Angélique Denis, Johann Colomba, Sandrine Touzet, Katherine Desjardins, Stéphanie Poupon Bourdy, Isabelle Durieu, Rémi Rabasa-Lhoret
Publikováno v:
PLoS ONE, Vol 16, Iss 3, p e0246897 (2021)
ObjectiveTo report the clinical profile associated with G60 and I60 over a 4-year prospective observational period in 2 large cohorts of adult patients with CF.Methods319 patients were included (210 Canadian and 119 French) and classified according t
Externí odkaz:
https://doaj.org/article/cdd67f6bf30d455eb49a69c9a5784772
Autor:
Johann Colomba, Silvia R Netedu, Catherine Lehoux-Dubois, Adèle Coriati, Valérie Boudreau, François Tremblay, Kenneth Cusi, Rémi Rabasa-Lhoret, Julio A Leey
Publikováno v:
PLoS ONE, Vol 14, Iss 7, p e0219855 (2019)
AimCystic fibrosis (CF) patients are at high risk of developing CF-related diabetes (CFRD). In non-CF patients, liver disease, specifically steatosis and non-alcoholic fatty liver disease (NAFLD), is strongly associated with type 2 diabetes. We compa
Externí odkaz:
https://doaj.org/article/5da7e69d8f6e44319987ec395485bc69
Publikováno v:
Frontiers in Endocrinology, Vol 9 (2019)
Physical activity is highly recommended for patients living with type 1 diabetes (T1D) due to its varied health benefits. Nevertheless, glucose management, during and in the hours following exercise, represents a great challenge for these patients wh
Externí odkaz:
https://doaj.org/article/428196901cc4406f9b1655430e4326d1